Topical corticosteroids remain a cornerstone of atopic dermatitis care, but steroid phobia and a growing roster of nonsteroidal agents are reshaping how clinicians use them. On this episode…
Exosomes in dermatology are moving closer to a regulatory pathway, and a new remibrutinib label update is changing how clinicians approach symptomatic dermographism. Todd Schlesinger, MD, shares the…
NEW YORK (Reuters Health) – Certain disease-modifying antirheumatic drugs (DMARDs) may lower the risk of diabetes in patients with rheumatoid arthritis (RA) or psoriasis, according to an observational…
NEW YORK (Reuters Health) – Overweight or obese children have a significantly higher prevalence of psoriasis and adolescents with psoriasis have elevated levels of blood lipids, researchers report…
NEW YORK (Reuters Health) – Methotrexate and azathioprine are similarly effective as systemic treatments for severe atopic dermatitis in adults, according to the results of a head-to-head trial…
NEW YORK (Reuters Health) – Azathioprine has a moderate therapeutic effect in atopic dermatitis, and may also be useful for other dermatologic conditions, according to a report in…
Gary Goldenberg, MD, Assistant Professor of Dermatology and Pathology, and Medical Director of the Faculty Practice at the Mount Sinai School of Medicine, discusses the pathophysiology and approach…
Gary Goldenberg, MD, Assistant Professor of Dermatology and Pathology, and Medical Director of the Faculty Practice at the Mount Sinai School of Medicine, discusses the pathophysiology and approach…
Vincent A. DeLeo, MD, Chairman, Department of Dermatology, St Luke’s – Roosevelt Hospital, New York, discusses sunscreens and FDA testing and labeling for photoprotection. The sunburn protection factor,…
Nanette B. Silverberg, MD, director of Pediatric and Adolescent Dermatology St. Luke’s – Roosevelt Hospital Center, New York, discusses melanoma and its increasing incidence. This has occurred in…
NEW YORK (Reuters Health) – The evaluation of pigmented lesions for early detection of melanoma is aided by the use of MelaFind, a non-invasive automated vision-computer system, according…
NEW YORK (Reuters Health) – Patients who have undergone prior systemic therapies for cutaneous T-cell lymphoma may respond well to treatment with romidepsin, a potent inhibitor of histone…
